JP2010535210A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010535210A5 JP2010535210A5 JP2010519922A JP2010519922A JP2010535210A5 JP 2010535210 A5 JP2010535210 A5 JP 2010535210A5 JP 2010519922 A JP2010519922 A JP 2010519922A JP 2010519922 A JP2010519922 A JP 2010519922A JP 2010535210 A5 JP2010535210 A5 JP 2010535210A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- ambrisentan
- glucuronidyl
- och
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 22
- OUJTZYPIHDYQMC-LJQANCHMSA-N ambrisentan Chemical compound O([C@@H](C(OC)(C=1C=CC=CC=1)C=1C=CC=CC=1)C(O)=O)C1=NC(C)=CC(C)=N1 OUJTZYPIHDYQMC-LJQANCHMSA-N 0.000 claims 8
- 229960002414 ambrisentan Drugs 0.000 claims 6
- 238000009472 formulation Methods 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 241000124008 Mammalia Species 0.000 claims 5
- 150000004677 hydrates Chemical class 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 239000012453 solvate Substances 0.000 claims 5
- 239000013543 active substance Substances 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 229940118365 Endothelin receptor antagonist Drugs 0.000 claims 1
- 210000000941 bile Anatomy 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000002308 endothelin receptor antagonist Substances 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 239000002207 metabolite Substances 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 0 *C(C(*)(c1ccccc1)c1ccccc1)Oc1nc(*)cc(*)n1 Chemical compound *C(C(*)(c1ccccc1)c1ccccc1)Oc1nc(*)cc(*)n1 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95305307P | 2007-07-31 | 2007-07-31 | |
| PCT/US2008/009236 WO2009017777A2 (en) | 2007-07-31 | 2008-07-31 | Metabolites and derivatives of ambrisentan |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010535210A JP2010535210A (ja) | 2010-11-18 |
| JP2010535210A5 true JP2010535210A5 (cg-RX-API-DMAC7.html) | 2011-05-19 |
Family
ID=39924953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010519922A Pending JP2010535210A (ja) | 2007-07-31 | 2008-07-31 | アンブリセンタンの代謝産物および誘導体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8217155B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2183223A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2010535210A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101801936B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008282773B8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2695259C (cg-RX-API-DMAC7.html) |
| MX (1) | MX2010001255A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009017777A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19533023B4 (de) | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| EP2952193A1 (en) | 2006-12-12 | 2015-12-09 | Gilead Sciences, Inc. | Composition for treating a pulmonary hypertension |
| AU2008282773B8 (en) | 2007-07-31 | 2013-03-07 | Gilead Sciences, Inc. | Metabolites and derivatives of ambrisentan |
| US9255931B2 (en) | 2010-06-24 | 2016-02-09 | Morehouse School Of Medicine | Method and compositions for the treatment and detection of endothelin-1 related kidney diseases |
| US20120269898A1 (en) | 2010-10-15 | 2012-10-25 | Luiz Belardinelli | Compositions and methods of treating pulmonary hypertension |
| CN102276536B (zh) | 2011-06-10 | 2015-04-29 | 中国科学院化学研究所 | 一种光学纯的(+)-安倍生坦和光学纯的(+)-达芦生坦的制备方法 |
| CN103012281B (zh) * | 2011-09-22 | 2015-04-08 | 江苏康缘药业股份有限公司 | 一种手性2-[(4,6-二甲基嘧啶-2-基)氧基]-3-甲氧基-3,3-二苯基丙酸的消旋化方法 |
| CN104280480B (zh) * | 2013-07-02 | 2016-12-28 | 天津药物研究院有限公司 | 一种分离检测安立生坦及其有关物质的方法 |
| CN104515816B (zh) * | 2013-09-29 | 2016-04-20 | 天津药物研究院 | 一种安立生坦原料及制剂有关物质的检测方法 |
| CN104359993B (zh) * | 2014-12-09 | 2016-03-30 | 江苏康缘药业股份有限公司 | 一种安立生坦有关物质的检测方法 |
| EP3235496A1 (en) * | 2016-04-19 | 2017-10-25 | Noorik Biopharmaceuticals AG | Treatment of acute renal failure |
| MX2022007471A (es) | 2019-12-17 | 2022-08-17 | Chinook Therapeutics Inc | Metodos de tratamiento de la nefropatia por iga con atrasentan. |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19533023B4 (de) | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| DE19726146A1 (de) | 1997-06-19 | 1998-12-24 | Basf Ag | Neue ß-Amino und ß-Azidopcarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
| DE19806438A1 (de) | 1998-02-17 | 1999-08-19 | Basf Ag | Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung |
| US6337328B1 (en) * | 1999-03-01 | 2002-01-08 | Sepracor, Inc. | Bupropion metabolites and methods of use |
| PA8652001A1 (es) * | 2004-11-05 | 2006-10-13 | Wyeth Corp | Metabolitos glucuronidos de tigeciclina y epimeros de los mismos |
| US20090131441A1 (en) * | 2005-01-25 | 2009-05-21 | Dompe Phar.R.Ma S.P.A. | Metabolites Of 2-Arylpropionic Acid Derivatives And Pharmaceutical Compositions Containing Them |
| WO2006083780A2 (en) * | 2005-01-31 | 2006-08-10 | Mylan Laboratories, Inc. | Glucuronidated nebivolol |
| CA2612268A1 (en) * | 2005-06-17 | 2006-12-28 | Pfizer Products Inc. | Metabolites of 1-[6-(1-ethyl-1-hydroxy-propyl)-pyridin-3-yl]-3-[2-(4-methyl-piperazin-1-yl)-benzyl]-pyrrolidin-2-one as seratonin receptor antagonists |
| EP2952193A1 (en) | 2006-12-12 | 2015-12-09 | Gilead Sciences, Inc. | Composition for treating a pulmonary hypertension |
| US20080139483A1 (en) | 2006-12-12 | 2008-06-12 | Gorczynski Richard J | Drug combination for hypertensive disorders |
| AU2008282773B8 (en) | 2007-07-31 | 2013-03-07 | Gilead Sciences, Inc. | Metabolites and derivatives of ambrisentan |
| WO2009026517A2 (en) | 2007-08-22 | 2009-02-26 | Gilead Colorado, Inc. | Therapy for complications of diabetes |
| WO2010062640A1 (en) | 2008-10-28 | 2010-06-03 | Gilead Colorado, Inc. | Methods for treating idiopathic pulmonary fibrosis and associated complications |
-
2008
- 2008-07-31 AU AU2008282773A patent/AU2008282773B8/en active Active
- 2008-07-31 EP EP08794904A patent/EP2183223A2/en not_active Withdrawn
- 2008-07-31 CA CA2695259A patent/CA2695259C/en active Active
- 2008-07-31 US US12/671,439 patent/US8217155B2/en active Active
- 2008-07-31 WO PCT/US2008/009236 patent/WO2009017777A2/en not_active Ceased
- 2008-07-31 CN CN2008801071505A patent/CN101801936B/zh not_active Expired - Fee Related
- 2008-07-31 JP JP2010519922A patent/JP2010535210A/ja active Pending
- 2008-07-31 MX MX2010001255A patent/MX2010001255A/es active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010535210A5 (cg-RX-API-DMAC7.html) | ||
| ES2554772T3 (es) | Azabenzoxazoles sustituidos novedosos | |
| TWI660947B (zh) | 用於合成造影劑及其中間體之方法及裝置 | |
| JP2024133410A (ja) | 心臓代謝の効率を高めるための組成物および方法 | |
| JP2008531468A5 (cg-RX-API-DMAC7.html) | ||
| JP2017088633A5 (cg-RX-API-DMAC7.html) | ||
| TW200522933A (en) | Muscarinic acetylcholine receptor antagonists | |
| JP2011511073A5 (cg-RX-API-DMAC7.html) | ||
| JP2009114217A5 (cg-RX-API-DMAC7.html) | ||
| RU2012113613A (ru) | Способ получения изображения кровоснабжения миокарда | |
| JP2018529742A (ja) | Ｅｚｈ２阻害剤を用いた髄芽腫の処置方法 | |
| KR20210137252A (ko) | 마취를 유도하는 방법 | |
| JP2009541209A5 (cg-RX-API-DMAC7.html) | ||
| CA2983312A1 (en) | Tetrahydronaphthyridinyl propionic acid derivatives and uses thereof | |
| JP2017534591A (ja) | 心肺障害の処置のためのスフィンゴシン−１−リン酸受容体モジュレーター | |
| CN104583192A (zh) | 适合于线粒体复合体-1检出的化合物 | |
| RU2008152751A (ru) | Соли тримебутина и n-десметилтримебутина | |
| RU2005131872A (ru) | Производные бензотиазола (варианты), фармацевтическая композиция для детекции отложений амилоида и способ их детекции у млекопитающего | |
| JP2013522328A (ja) | ２’，２−ビスチアゾール非ヌクレオシド系化合物及びその調製方法、医薬組成物、及び抗肝炎ウイルス阻害剤としての用途 | |
| JP2009538894A5 (cg-RX-API-DMAC7.html) | ||
| JP2008528440A5 (cg-RX-API-DMAC7.html) | ||
| JP2013507345A5 (cg-RX-API-DMAC7.html) | ||
| US9174951B2 (en) | Glucose transporter inhibitors | |
| RU2007132081A (ru) | Способ и композиция для лечения заболеваний центральной нервной системы | |
| CN114929219A (zh) | 使用整联蛋白抑制剂组合治疗肝脏疾病 |